or Try an Advanced Search...

    Technical Analysis for ACON - Aclarion, Inc.

    Grade Last Price % Change Price Change
    F 0.18 -0.06% 0.00
    ACON closed down 0.06 percent on Wednesday, November 20, 2024, on 32 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ACON trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.06%
    Inside Day Range Contraction -0.06%
    Gapped Down Weakness -0.06%
    Oversold Stochastic Weakness -0.06%
    50 DMA Resistance Bearish 0.97%
    Stochastic Buy Signal Bullish 0.97%
    Wide Bands Range Expansion 0.97%
    Oversold Stochastic Weakness 0.97%
    New 52 Week Closing Low Bearish 8.02%
    Outside Day Range Expansion 8.02%
    Older End-of-Day Signals for ACON ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day 1 day ago
    Down 5% 2 days ago
    Down 3% 2 days ago
    Down 2 % 2 days ago
    Down 1% 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ACON Chart by TradingView
    Basic chart:

    Profile

    Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
    Classification
    Sector: Healthcare
    Industry: Health Information Services
    Keywords: Biotechnology Life Sciences Natural Sciences Software Application Biomarkers Healthcare Technology Spectroscopy Chemical Pathology

    Is ACON a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
    Nov 4 Aclarion files to sell 27.52M shares of common stock for holders
    Oct 25 Aclarion files to sell 20M shares of common stocks by selling shareholders
    Oct 10 Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
    Sep 27 Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
    Sep 13 PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
    Sep 12 Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
    Sep 11 Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
    Sep 10 Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
    Sep 6 Aclarion Added to PRISM Emerging Medical Devices Index
    See more ACON news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.3984
    52 Week Low 0.1599
    Average Volume 419,036
    200-Day Moving Average 0.35
    50-Day Moving Average 0.18
    20-Day Moving Average 0.18
    10-Day Moving Average 0.18
    Average True Range 0.02
    RSI (14) 47.37
    ADX 28.11
    +DI 19.16
    -DI 12.08
    Chandelier Exit (Long, 3 ATRs) 0.19
    Chandelier Exit (Short, 3 ATRs) 0.21
    Upper Bollinger Bands 0.21
    Lower Bollinger Band 0.16
    Percent B (%b) 0.31
    BandWidth 24.66
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram -0.0013
    Fundamentals Value
    Market Cap 341.43 Thousand
    Num Shares 1.94 Million
    EPS -9.28
    Price-to-Earnings (P/E) Ratio -0.02
    Price-to-Sales 42.56
    Price-to-Book 1.91
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.19
    Resistance 3 (R3) 0.19 0.19 0.19
    Resistance 2 (R2) 0.19 0.18 0.19 0.19
    Resistance 1 (R1) 0.18 0.18 0.18 0.18 0.19
    Pivot Point 0.17 0.17 0.18 0.18 0.17
    Support 1 (S1) 0.17 0.17 0.17 0.17 0.16
    Support 2 (S2) 0.16 0.17 0.16 0.16
    Support 3 (S3) 0.16 0.16 0.16
    Support 4 (S4) 0.16